NTAP
60
2
EMN
70
-2
CME
42
-4
RF
51
-2
FAST
46
-3
TGNA
48
-2
IPG
39
-3
ILMN
41
-3
RRC
56
4
EMC
53
-3
O
31
3
LH
48
-2
INTC
43
6
KMI
59
2
THC
61
-3
MU
34
3
CCL
68
-4
T
56
2
TRV
64
2
MDT
53
-2
NTAP
60
2
EMN
70
-2
CME
42
-4
RF
51
-2
FAST
46
-3
TGNA
48
-2
IPG
39
-3
ILMN
41
-3
RRC
56
4
EMC
53
-3
O
31
3
LH
48
-2
INTC
43
6
KMI
59
2
THC
61
-3
MU
34
3
CCL
68
-4
T
56
2
TRV
64
2
MDT
53
-2
Financhill
Back

First Trust US Equity Opportunities ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
73

FPX
First Trust US Equity Opportunities ETF

Last Price:
110.27
Seasonality Move:
1.54%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
73
First Trust US Equity Opportunities ETF (FPX) is a Buy

Is First Trust US Equity Opportunities ETF a Buy, Sell or Hold?

  • The current First Trust US Equity Opportunities ETF [FPX] share price is $110.55. The Score for FPX is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • FPX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

FPX Stock Price Chart

What is First Trust US Equity Opportunities ETF's stock price today?

  • The First Trust US Equity Opportunities ETF share price today is $110.55
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FPX is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

FPX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.22 Buy
Relative Strength Index (14 RSI): 73.86 Buy
Chaikin Money Flow: 10323 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.25 - 106.05) Buy
Bollinger Bands (100): (97.87 - 103.83) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

FPX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 106.44 Buy
20-day SMA: 103.48 Buy
50-day SMA: 100.88 Buy
200-day SMA: 99.63 Buy
8-day EMA: 106.81 Buy
20-day EMA: 104.11 Buy
50-day EMA: 101.94 Buy
200-day EMA: 98.46 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

First Trust US Equity Opportunities ETF Earnings Growth & FPX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

First Trust US Equity Opportunities ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):